Your browser doesn't support javascript.
loading
Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.
Ciavarella, S; Vegliante, M C; Fabbri, M; De Summa, S; Melle, F; Motta, G; De Iuliis, V; Opinto, G; Enjuanes, A; Rega, S; Gulino, A; Agostinelli, C; Scattone, A; Tommasi, S; Mangia, A; Mele, F; Simone, G; Zito, A F; Ingravallo, G; Vitolo, U; Chiappella, A; Tarella, C; Gianni, A M; Rambaldi, A; Zinzani, P L; Casadei, B; Derenzini, E; Loseto, G; Pileri, A; Tabanelli, V; Fiori, S; Rivas-Delgado, A; López-Guillermo, A; Venesio, T; Sapino, A; Campo, E; Tripodo, C; Guarini, A; Pileri, S A.
Affiliation
  • Ciavarella S; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari.
  • Vegliante MC; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari.
  • Fabbri M; Division of Diagnostic Haematopathology, European Institute of Oncology, IRCCS, Milan.
  • De Summa S; Molecular Diagnostics and Pharmacogenetics Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari.
  • Melle F; Division of Diagnostic Haematopathology, European Institute of Oncology, IRCCS, Milan.
  • Motta G; Division of Diagnostic Haematopathology, European Institute of Oncology, IRCCS, Milan.
  • De Iuliis V; Post-graduated Medical School of Clinical Pathology, "Gabriele D'Annunzio", University of Chieti, Chieti.
  • Opinto G; Functional Biomorphology Laboratory, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
  • Enjuanes A; Unitat de Genòmica, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona; CIBERONC, Barcelona, Spain.
  • Rega S; Pathology Department, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari.
  • Gulino A; Tumor Immunology Unit, Dipartimento per la Promozione della Salute e Materno Infantile "G. D'Alessandro", University of Palermo, Palermo.
  • Agostinelli C; Department of Experimental, Diagnostic, and Specialty Medicine (DIMES), Bologna University School of Medicine, Bologna.
  • Scattone A; Pathology Department, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari.
  • Tommasi S; Molecular Diagnostics and Pharmacogenetics Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari.
  • Mangia A; Functional Biomorphology Laboratory, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
  • Mele F; Pathology Department, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari.
  • Simone G; Pathology Department, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari.
  • Zito AF; Pathology Department, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari.
  • Ingravallo G; Pathology Section, Department of Emergency and Organ Transplantation (DETO), University of Bari "Aldo Moro", Bari.
  • Vitolo U; Department of Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino.
  • Chiappella A; Department of Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino.
  • Tarella C; Onco-Hematology Unit, European Institute of Oncology, IRCCS, Milan.
  • Gianni AM; Onco-Hematology Unit, European Institute of Oncology, IRCCS, Milan.
  • Rambaldi A; Department of Hematology and Oncology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo; School of Medicine, University of Milan, Milan, Italy.
  • Zinzani PL; Department of Experimental, Diagnostic, and Specialty Medicine (DIMES), Bologna University School of Medicine, Bologna.
  • Casadei B; Department of Experimental, Diagnostic, and Specialty Medicine (DIMES), Bologna University School of Medicine, Bologna.
  • Derenzini E; Onco-Hematology Unit, European Institute of Oncology, IRCCS, Milan.
  • Loseto G; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari.
  • Pileri A; Department of Experimental, Diagnostic, and Specialty Medicine (DIMES), Bologna University School of Medicine, Bologna.
  • Tabanelli V; Division of Diagnostic Haematopathology, European Institute of Oncology, IRCCS, Milan.
  • Fiori S; Division of Diagnostic Haematopathology, European Institute of Oncology, IRCCS, Milan.
  • Rivas-Delgado A; CIBERONC, Barcelona, Spain; Hematology Department, Hospital Clínic, Barcelona; IDIBAPS, Barcelona, Spain.
  • López-Guillermo A; CIBERONC, Barcelona, Spain; Hematology Department, Hospital Clínic, Barcelona; IDIBAPS, Barcelona, Spain.
  • Venesio T; Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy.
  • Sapino A; Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy; Department of Medical Sciences, University of Torino, Turin, Italy.
  • Campo E; CIBERONC, Barcelona, Spain; Haematopathology Unit, Pathology Department, Hospital Clínic, Barcelona; University of Barcelona, Barcelona, Spain.
  • Tripodo C; Pathology Department, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari.
  • Guarini A; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari.
  • Pileri SA; Division of Diagnostic Haematopathology, European Institute of Oncology, IRCCS, Milan.
Ann Oncol ; 30(12): 2015, 2019 12 01.
Article in En | MEDLINE | ID: mdl-31539020
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Type: Article